 |
Press Release
BurnsAdler Pharmaceuticals, Inc. Announces
Ernest C. Bourne will Join the Company as Chairman of the Board
Charlotte, North Carolina - (October 21, 2002) - BurnsAdler Pharmaceuticals, Inc. (“BurnsAdler”) announced today that Ernest C. Bourne had accepted the position of Chairman of the Board. Mr. Bourne comes to the company from King Pharmaceuticals, Inc. where he was a member of the Board of Directors as well as the founder and President of King’s International division.
R. Banks Bourne, President of BurnsAdler, stated, “Ernie’s international transaction and operating experience with King Pharmaceuticals and prior investment banking career is a great asset to our company. We are pleased he has accepted the Chairman position in our company and know his leadership will make a significant contribution to BurnsAdler.”
Ernie Bourne stated, “King Pharmaceuticals has been an exceptional story and with the management team in place I felt like the time was right to join BurnsAdler. BurnsAdler’s internationally focused business model is a novel one to the pharmaceutical industry and it fills a market void for many pharmaceutical companies across the world. I look forward to making a positive contribution to the company.”
BurnsAdler is an internationally focused specialty pharmaceutical company. The Company provides international import and promotion of products for select emerging pharmaceutical companies primarily headquartered in North America and Europe. BurnsAdler maintains long term, exclusive agreements with its pharmaceutical company partners to license, supply and market products in Canada, Mexico, Central America, South America, Europe and the Far East.
For additional information about this news release contact Molly Whitehurst at +1.704.770.0994. Find additional information about BurnsAdler at www.burnsadler.com.
|
BurnsAdler provides cost effective international product distribution and promotion for select emerging pharmaceutical companies.
 Print this page.
|
